Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by pelabooston Sep 18, 2024 12:39pm
95 Views
Post# 36229232

Accelerated Approval

Accelerated Approval
It was me, from my layman's lair who dug up Accelerated Approval. I was impelled to do so by the rather astonishing results from GOBLET. That is to say, look for a quicker route for pelareorep.

I have never understood, from my layman's perspective why things after the impressive Bernstein trial are so complicated. The Adlai Nortye association leaves serious doubts about the approach taken, and frankly that deal did not make much sense then or now.

Noteable seems to understand the matter, and to my thinking won the recent AA argument.

To me, and I may be naive, ONC/Y seems to br righting the ship, and may already have done so.

Cheers


<< Previous
Bullboard Posts
Next >>